University of California San Francisco (UCSF)

Development of a Magnetic Resonance Imaging–Based Definition of Knee Osteoarthritis: Data From the Multicenter Osteoarthritis Study (2023) Liew JW, Rabasa G, LaValley M, Collins J, Stefanik J, Roemer F, Guermazi A, et al. Journal article Early knee OA definition–what do we know at this stage? An imaging perspective (2023) Li X, Roemer F, Cicuttini F, Mackay JW, Turmezei T, Link TM Journal article, Review article Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison (2023) Rugo HSS, Harmer V, O'Shaughnessy J, Jhaveri K, Tolaney SMM, Cardoso F, Bardia A, et al. Journal article Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia (2023) Schneider H, Hadj-Rabia S, Faschingbauer F, Bodemer C, Grange DK, Norton ME, Cavalli R, et al. Journal article Analysis of Hand Joint Space Morphology in Women and Men with Hereditary Hemochromatosis (2023) Heilmeier U, Burghardt AJ, Tse JJ, Kapoor P, Stok KS, Manske S, Voll RE, et al. Journal article Unique roles of co-receptor-bound LCK in helper and cytotoxic T cells (2023) Horkova V, Drobek A, Paprckova D, Niederlova V, Prasai A, Uleri V, Glatzova D, et al. Journal article Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. (2023) Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar De Pinho N, et al. Journal article Altered early immune response after fracture and traumatic brain injury. (2023) Haffner-Luntzer M, Weber B, Morioka K, Lackner I, Fischer V, Bahney C, Ignatius A, et al. Journal article Detecting Parkinson’s disease and its cognitive phenotypes via automated semantic analyses of action stories (2022) García AM, Escobar-Grisales D, Vásquez Correa JC, Bocanegra Y, Moreno L, Carmona J, Orozco Arroyave JR Journal article Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study (2022) Wong SW, Bar N, Paris L, Hofmeister CC, Hansson M, Santoro A, Mateos MV, et al. Conference contribution